The future of oncology: new technologies and tailored treatment

06/18/24 • 31 min

The past few decades have witnessed significant strides in how cancer is detected, diagnosed and treated, leading to a noticeable decrease in mortality rates in many countries.

These improvements are largely due to new discoveries about why and how cancer develops, generating new ways of treating cancer to help people live longer, healthier lives.

From immunotherapy and AI to cancer vaccines - Cary Adams, CEO of UICC speaks with Dr Laszlo Radvanyi, President and Scientific Director of the Ontario Institute for Cancer Research, an internationally renowned research institute located in Toronto, Canada, who is at the forefront of some of the most ground-breaking work in cancer research.

Hosted on Acast. See acast.com/privacy for more information.

The past few decades have witnessed significant strides in how cancer is detected, diagnosed and treated, leading to a noticeable decrease in mortality rates in many countries.

These improvements are largely due to new discoveries about why and how cancer develops, generating new ways of treating cancer to help people live longer, healthier lives.

Hosted on Acast. See acast.com/privacy for more information.

Previous Episode

Protecting youth from tobacco industry interference

Around 8 million people die because of tobacco consumption every single year, leading the tobacco industry to search for new users. Increasingly, it is targeting youth in the hope of hooking a new generation to tobacco products and creating lifelong consumers. To protect youth from tobacco industry interference, we must ensure that their perspectives are heard.

In this episode of Let’s Talk Cancer, Cary Adams, CEO of UICC speaks with Agamroop Kaur, National Youth Advocate of the Year of the Campaign for Tobacco-Free Kids and David Planas Maluenda, global health policymaker at the Spanish Association Against Cancer in Zaragoza and Youth Ambassador Against Cancer at the European Cancer Leagues.

Hosted on Acast. See acast.com/privacy for more information.

Next Episode

Antimicrobial resistance (AMR): a rising threat to cancer treatment

Antimicrobial resistance, also known as AMR or drug resistance, is among the top 10 public health threats facing humanity, according to the World Health Organization.

Antimicrobial resistance happens when the medicines, including antiotics, are no longer able to fight infections from bacteria, fungi, viruses and parasites.

For cancer patients, the situation is particularly concerning. They have particularly weak immune systems due to the cancer treatment, such as chemotherapy, they are receiving and are therefore more prone to infections. As many as 1 in 5 cancer patients undergoing treatment are hospitalised due to infection. Antibiotics are critical to treat them.

Moreover, the growth of drug-resistant bacteria is undermining the key advances that have been made in surgery, radiotherapy and immunotherapies, as treatment is delayed or stopped to treat rising infections.

Malin Grape is Sweden’s – and the world’s – first Ambassador on AMR, working to counteract AMR and its consequences in the EU and internationally. She joins us for this episode of “Let’s Talk Cancer” ahead of the upcoming UN high-level meeting in September on AMR.

Hosted on Acast. See acast.com/privacy for more information.